Cantor Fitzgerald’s Verastem VSTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$535K Sell
140,000
-223,132
-61% -$1.08M 0.01% 278
2026
Q1
$1.92M Buy
363,132
+320,881
+759% +$1.98M 0.03% 155
2025
Q4
$326K Buy
+42,251
New +$377K ﹤0.01% 193

Other funds holding VSTM

Cantor Fitzgerald's VSTM Position: Q2 2026 in Review

Cantor Fitzgerald reduced its Verastem (VSTM) stake by 61% in Q2 2026, selling an estimated $1.08M and leaving 140,000 shares worth $535K. The position accounts for 0.01% of the portfolio, ranked #278.

Cantor Fitzgerald first reported a position in VSTM in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.92M in Q1 2026. 157 funds tracked by Wall St. Rank hold VSTM as of Q2 2026.

  • Cantor Fitzgerald held 140,000 shares of Verastem worth $535K as of Q2 2026.
  • Cantor Fitzgerald sold 223,132 Verastem shares in Q2 2026, an estimated $1.08M.
  • Verastem made up 0.01% of Cantor Fitzgerald's portfolio in Q2 2026, its #278 holding.
  • Cantor Fitzgerald first reported a position in Verastem in Q4 2025 and has held it in 3 quarters since.
  • Cantor Fitzgerald's Verastem position peaked at $1.92M in Q1 2026.
  • 157 funds tracked by Wall St. Rank held Verastem as of Q2 2026.

Based on Cantor Fitzgerald's 13F filing for Q2 2026, filed 14 Aug 2026.